| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Markus Schürks | Q78712697 |
| P2093 | author name string | Dieter Rosskopf | |
| Christian Rimmbach | |||
| Rafael Schäfers | |||
| P2860 | cites work | Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III | Q24317311 |
| Association of a human G-protein beta3 subunit variant with hypertension | Q24319177 | ||
| A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension | Q24538746 | ||
| Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4 | Q24541348 | ||
| Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency | Q24561534 | ||
| Identification of a PY motif in the epithelial Na channel subunits as a target sequence for mutations causing channel activation found in Liddle syndrome | Q24563016 | ||
| WW domains of Nedd4 bind to the proline-rich PY motifs in the epithelial Na+ channel deleted in Liddle's syndrome | Q24563029 | ||
| Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2 | Q24564081 | ||
| A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity | Q24564608 | ||
| A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate | Q24613583 | ||
| RGS2/G0S8 is a selective inhibitor of Gqalpha function | Q24648296 | ||
| A genetic defect resulting in mild low-renin hypertension | Q24669744 | ||
| Familial aggregation of blood pressure in 558 adopted children | Q24680323 | ||
| Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy | Q28140188 | ||
| G protein beta 3 gene: structure, promoter, and additional polymorphisms | Q28141391 | ||
| Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension | Q28145697 | ||
| Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patients | Q28181588 | ||
| Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure | Q28203023 | ||
| Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase | Q28208090 | ||
| beta-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations | Q28209012 | ||
| Identification of RGS2 and type V adenylyl cyclase interaction sites | Q28211957 | ||
| Human hypertension caused by mutations in WNK kinases | Q28212182 | ||
| Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension | Q28238039 | ||
| Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel | Q28240272 | ||
| Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects | Q28242801 | ||
| WNK kinases regulate sodium chloride and potassium transport by the aldosterone-sensitive distal nephron | Q28250388 | ||
| Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension | Q28257529 | ||
| No association with hypertension of CLCNKB and TNFRSF1B polymorphisms at a hypertension locus on chromosome 1p36 | Q28260486 | ||
| Activating mutation of the renal epithelial chloride channel ClC-Kb, predisposing to hypertension | Q28262218 | ||
| A family with Liddle's syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel | Q28273651 | ||
| Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1 | Q28275138 | ||
| Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated | Q28281477 | ||
| Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. | Q35882777 | ||
| Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone | Q35918455 | ||
| Functional genomics of the dopaminergic system in hypertension | Q35952875 | ||
| Adducin polymorphism: detection and impact on hypertension and related disorders | Q36033843 | ||
| Pharmacogenomics of blood pressure response to antihypertensive treatment | Q36155230 | ||
| Six truisms concerning ACE and the renin-angiotensin system educed from the genetic analysis of mice | Q36157768 | ||
| Meta-analysis of the ACE gene in ischaemic stroke | Q36317849 | ||
| ACE polymorphisms | Q36475898 | ||
| Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations | Q37360005 | ||
| A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro | Q37365783 | ||
| Angiotensinogen T235 expression is elevated in decidual spiral arteries | Q37372462 | ||
| Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression | Q37388093 | ||
| The genetic polymorphism of debrisoquine/sparteine metabolism--clinical aspects | Q37924766 | ||
| Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit | Q38290561 | ||
| The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension | Q38324554 | ||
| Polymorphism of gamma-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55. | Q38343325 | ||
| RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling | Q38344549 | ||
| Angiotensinogen Met235Thr polymorphism, angiotensin-converting enzyme inhibitor therapy, and the risk of nonfatal stroke or myocardial infarction in hypertensive patients | Q38481357 | ||
| Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension | Q38489772 | ||
| Phosphatidylinositol 3-kinase-mediated endocytosis of renal Na+, K+-ATPase alpha subunit in response to dopamine | Q38611404 | ||
| Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity | Q39116365 | ||
| Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. | Q39517168 | ||
| Neurogenic hypertension: etiology and surgical treatment. I. Observations in 53 patients | Q39549885 | ||
| Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit | Q39635647 | ||
| Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension | Q40305844 | ||
| Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop | Q40417203 | ||
| Spinophilin regulates Ca2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors | Q40442171 | ||
| Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol | Q40576862 | ||
| Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins | Q40663703 | ||
| Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients | Q40682400 | ||
| Tyrosine 537 within the Na+,K+-ATPase alpha-subunit is essential for AP-2 binding and clathrin-dependent endocytosis | Q40749040 | ||
| Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking | Q40757155 | ||
| Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension | Q40857373 | ||
| Angiotensin I-converting enzyme gene polymorphism and acute response to captopril in essential hypertension | Q40879855 | ||
| Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells | Q40980335 | ||
| Renal mechanisms of genetic hypertension: from the molecular level to the intact organism | Q41066735 | ||
| Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan | Q41597193 | ||
| Association between the angiotensinogen 235T-variant and essential hypertension in whites: a systematic review and methodological appraisal. | Q41665134 | ||
| Liddle's syndrome | Q41743739 | ||
| Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. | Q42102644 | ||
| Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene | Q42467428 | ||
| A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor | Q42490743 | ||
| Severely impaired baroreflex-buffering in patients with monogenic hypertension and neurovascular contact | Q42496275 | ||
| Deletion at 12p in a Japanese child with brachydactyly overlaps the assigned locus of brachydactyly with hypertension in a Turkish family | Q43108960 | ||
| Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes | Q43612366 | ||
| Post-transcriptional regulation of the AT1 receptor mRNA. Identification of the mRNA binding motif and functional characterization | Q43626616 | ||
| The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis | Q48951069 | ||
| Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. | Q50866265 | ||
| Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. | Q50885930 | ||
| Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. | Q50994672 | ||
| Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. | Q51553957 | ||
| Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. | Q51958230 | ||
| An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. | Q52019856 | ||
| Linkage analysis of candidate genes and gene-gene interactions in chinese hypertensive sib pairs. | Q52211595 | ||
| Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. | Q52375631 | ||
| Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system. | Q52413462 | ||
| M235T angiotensinogen gene polymorphism and cardiovascular renal risk. | Q52910086 | ||
| Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. | Q53003916 | ||
| Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. | Q54197421 | ||
| Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. | Q54350600 | ||
| beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. | Q54594315 | ||
| Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. | Q54752863 | ||
| Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. | Q55067356 | ||
| A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension | Q55671192 | ||
| Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis | Q56893651 | ||
| Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study | Q56970838 | ||
| Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p | Q56982381 | ||
| A cross-over medication trial for patients with autosomal-dominant hypertension with brachydactyly | Q56982819 | ||
| Posterior fossa neurovascular anomalies in essential hypertension | Q56983100 | ||
| The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk | Q57085852 | ||
| Linkage of the Angiotensinogen Gene to Essential Hypertension | Q57282024 | ||
| Cardiovascular risk factors in a french canadian population: Resolution of genetic and familial environmental effects on blood pressure using twins, adoptees, and extensive information on environmental correlates | Q57316028 | ||
| Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes | Q57378094 | ||
| ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy | Q57397144 | ||
| Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction | Q57606113 | ||
| Apparent mineralocorticoid excess in a Brazilian kindred | Q57632859 | ||
| Angiotensin II type 1 receptor−153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects | Q59275530 | ||
| Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism | Q59311911 | ||
| Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women | Q59367291 | ||
| G-Protein β3 Subunit Gene ( GNB3 ) Variant in Causation of Essential Hypertension | Q59590798 | ||
| α-Adducin 460Trp Allele Is Associated With Erythrocyte Na Transport Rate in North Sardinian Primary Hypertensives | Q61466149 | ||
| Angiotensin-I converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta-analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects | Q61771206 | ||
| Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21 | Q64050276 | ||
| Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes | Q67729249 | ||
| Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity | Q70978480 | ||
| Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12 | Q71167669 | ||
| Angiotensin-converting enzyme gene polymorphism in hypertensive individuals with parental history of stroke | Q71477302 | ||
| Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK | Q71614570 | ||
| Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies | Q71953141 | ||
| The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension | Q71959530 | ||
| Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension | Q72036783 | ||
| Brief report: Liddle's syndrome revisited--a disorder of sodium reabsorption in the distal tubule | Q72666321 | ||
| Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese | Q72791685 | ||
| DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy | Q72893483 | ||
| Angiotensinogen and angiotensin-converting enzyme genotypes, and day and night blood pressures in elderly Japanese hypertensives | Q72992037 | ||
| A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor | Q22009445 | ||
| Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor | Q22254872 | ||
| A comprehensive review of genetic association studies | Q22337119 | ||
| Adducin: structure, function and regulation | Q24290117 | ||
| Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure | Q24299443 | ||
| A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin | Q24302509 | ||
| Rocks: multifunctional kinases in cell behaviour | Q24303641 | ||
| A molecular variant of angiotensinogen associated with preeclampsia | Q24309422 | ||
| Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel | Q24310075 | ||
| Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter | Q24311551 | ||
| Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2 | Q24313292 | ||
| A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families | Q24313454 | ||
| Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I | Q24315663 | ||
| Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age | Q28283140 | ||
| Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome | Q28288744 | ||
| Hypertension-linked mutation in the adducin alpha-subunit leads to higher AP2-mu2 phosphorylation and impaired Na+,K+-ATPase trafficking in response to GPCR signals and intracellular sodium | Q28291873 | ||
| Human hypertension caused by mutations in the kidney isozyme of 11β–hydroxysteroid dehydrogenase | Q28297160 | ||
| Genetic diseases associated with heterotrimeric G proteins | Q28306180 | ||
| Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype | Q28319529 | ||
| A novel mouse Nedd4 protein suppresses the activity of the epithelial Na+ channel | Q28512481 | ||
| Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport | Q28575497 | ||
| WNK kinases regulate thiazide-sensitive Na-Cl cotransport | Q28584824 | ||
| Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking | Q30169021 | ||
| G protein-coupled receptor kinase 4 gene variants in human essential hypertension | Q30309044 | ||
| Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. | Q30310235 | ||
| In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans | Q30320973 | ||
| Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation | Q30842107 | ||
| SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene: analysis of Nigerian family data using gamete competition models. | Q30983108 | ||
| C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic | Q32072905 | ||
| RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. | Q32102010 | ||
| G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension | Q32184390 | ||
| Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency | Q33557866 | ||
| Hereditary Brachydactyly Associated with Hypertension | Q33585733 | ||
| Gene targeting approaches to analyzing hypertension. | Q33686736 | ||
| Glucocorticoid-remediable aldosteronism and pregnancy | Q33840800 | ||
| QTL influencing blood pressure maps to the region of PPH1 on chromosome 2q31-34 in Old Order Amish | Q33906173 | ||
| Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study | Q33922221 | ||
| Three ways to make a vesicle | Q33938411 | ||
| Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism | Q33938773 | ||
| Angiotensinogen as a risk factor for essential hypertension in Japan | Q34133604 | ||
| Localization of a small genomic region associated with elevated ACE | Q34146741 | ||
| Antihypertensive pharmacogenetics: getting the right drug into the right patient | Q34154660 | ||
| Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice | Q34177503 | ||
| Genetic variants of WNK4 in whites and African Americans with hypertension | Q34193390 | ||
| Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis | Q34205648 | ||
| Genome-wide mapping of human loci for essential hypertension | Q34208939 | ||
| The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results | Q34236470 | ||
| A splice variant of the G protein beta 3-subunit implicated in disease states does not modulate ion channels | Q73023589 | ||
| 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II | Q73026265 | ||
| The role of alpha-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study | Q73087451 | ||
| Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese | Q73103576 | ||
| Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension | Q73186366 | ||
| Association between the C825T polymorphism of the G protein beta3-subunit gene and hypertension in blacks | Q73279512 | ||
| G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension | Q73371623 | ||
| Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension | Q73371731 | ||
| ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites | Q73435170 | ||
| Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells | Q73487478 | ||
| Angiotensin II type 1 receptor gene A1166C polymorphism is associated with the increased risk of pregnancy-induced hypertension | Q73512417 | ||
| Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese | Q73567299 | ||
| Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene | Q73569431 | ||
| Association of a polymorphism at the 5'-region of the angiotensin II type 1 receptor with hypertension | Q73607029 | ||
| Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype | Q73623120 | ||
| Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators | Q73858290 | ||
| Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension | Q73929740 | ||
| Mutations in the Na-Cl cotransporter reduce blood pressure in humans | Q74026246 | ||
| A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension | Q74052384 | ||
| Polymorphism in the beta(1)-adrenergic receptor gene and hypertension | Q74180003 | ||
| Association of sodium channel gamma-subunit promoter variant with blood pressure | Q74236463 | ||
| Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet | Q74316955 | ||
| Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism | Q74351904 | ||
| Determination of human beta(2)-adrenoceptor haplotypes by denaturation selective amplification and subtractive genotyping | Q74361626 | ||
| Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension | Q74385774 | ||
| Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle | Q74418601 | ||
| Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis | Q74601044 | ||
| Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension | Q74615293 | ||
| Association of GNAS1 gene variant with hypertension depending on smoking status | Q74742298 | ||
| Families with autosomal dominant brachydactyly type E, short stature, and severe hypertension | Q77060899 | ||
| Association of a sodium channel alpha subunit promoter variant with blood pressure | Q77374106 | ||
| Destabilization of AT(1) receptor mRNA by calreticulin | Q77475998 | ||
| The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects | Q77478556 | ||
| ACE (I/D) genotype as a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans | Q77554983 | ||
| Polymorphisms of the beta2 -adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies | Q77579720 | ||
| Freely associating | Q77729306 | ||
| Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke | Q77905014 | ||
| Association of the G(s)alpha gene with essential hypertension and response to beta-blockade | Q78002981 | ||
| Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II-receptor gene and the renin loci in man | Q78124937 | ||
| Linkage analysis of twelve candidate gene loci regulating water and sodium metabolism and membrane ion transport in essential hypertension | Q78309515 | ||
| Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele | Q78744681 | ||
| Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension | Q43642189 | ||
| Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. | Q43717170 | ||
| Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia | Q43796188 | ||
| Angiotensinogen gene core promoter variants and non-modulating hypertension | Q43829648 | ||
| Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure | Q43922014 | ||
| Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide | Q44173366 | ||
| Effects of ACE I/D and AT1R-A1166C polymorphisms on blood pressure in a healthy normotensive primary care population: first results of the Hippocates study | Q44289108 | ||
| A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade | Q44413115 | ||
| Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects | Q44502142 | ||
| Association of the GNAS1 gene variant with hypertension is dependent on alcohol consumption | Q44513761 | ||
| The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition | Q44553741 | ||
| Angiotensin II-mediated cellular responses: a role for the 3'-untranslated region of the angiotensin AT1 receptor | Q44582030 | ||
| Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol | Q44611160 | ||
| Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein β3 subunit gene (GNB3) | Q44637341 | ||
| Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial | Q44710151 | ||
| Autosomal-dominant hypertension with type E brachydactyly is caused by rearrangement on the short arm of chromosome 12. | Q44715090 | ||
| Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies | Q44745690 | ||
| WNK4 intron 10 polymorphism is not associated with hypertension | Q44766964 | ||
| Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension | Q44966749 | ||
| Molecular basis of human hypertension: role of angiotensinogen | Q45118696 | ||
| Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism | Q45145996 | ||
| Hypertension and Severe Hyperkalaemia Associated with Suppression of Renin and Aldosterone and Completely Reversed by Dietary Sodium Restriction | Q45163111 | ||
| Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population--the Suita Study | Q45238928 | ||
| Structural characterization of normal and mutant human steroid 17 alpha-hydroxylase genes: molecular basis of one example of combined 17 alpha-hydroxylase/17,20 lyase deficiency | Q45345344 | ||
| Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. | Q45984379 | ||
| Associations between hypertension and genes in the renin-angiotensin system. | Q46167954 | ||
| Polymorphisms of the gamma subunit of the epithelial Na+ channel in essential hypertension | Q46171808 | ||
| beta-2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians | Q46243319 | ||
| Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade | Q46388237 | ||
| Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. | Q46389857 | ||
| Genetics of human hypertension | Q46420746 | ||
| Association of a GNAS1 gene variant with hypertension and diabetes mellitus | Q46491364 | ||
| G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke | Q46539080 | ||
| Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3). | Q46551894 | ||
| T594M variant of the epithelial sodium channel beta-subunit gene and hypertension in individuals of African ancestry in South Africa. | Q46581101 | ||
| Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London | Q46590647 | ||
| Vascular smooth muscle overexpression of G protein-coupled receptor kinase 5 elevates blood pressure, which segregates with sex and is dependent on Gi-mediated signaling | Q46652728 | ||
| Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride | Q46667408 | ||
| Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study | Q46731232 | ||
| Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. | Q46748212 | ||
| Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population | Q46814882 | ||
| Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans | Q46887790 | ||
| Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity | Q46933292 | ||
| Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. | Q46946284 | ||
| beta-2 adrenergic receptor gene variations, blood pressure, and heart size in normal twins | Q47246737 | ||
| Two quantitative trait loci affect ACE activities in Mexican-Americans | Q47282894 | ||
| Blood pressure in relation to three candidate genes in a Chinese population. | Q47733615 | ||
| Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade | Q47803207 | ||
| A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene | Q47888290 | ||
| The T-allele of the C825T polymorphism is associated with higher arterial stiffness in young healthy males | Q47901790 | ||
| Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study | Q48026232 | ||
| Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males | Q48035561 | ||
| Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly | Q48626109 | ||
| Renin-angiotensin system genetic polymorphisms and cerebral white matter lesions in essential hypertension | Q48667673 | ||
| A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans | Q78861726 | ||
| Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families | Q78906952 | ||
| Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER Project | Q79080495 | ||
| Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide | Q79156049 | ||
| A molecular switch controlling renal sodium and potassium excretion | Q79333308 | ||
| Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule | Q80238253 | ||
| Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats | Q80841917 | ||
| The beta2-adrenoceptor gene and hypertension: is it the promoter or the coding region or neither? | Q83311011 | ||
| Cellular mechanisms of WNK4-mediated regulation of ion transport proteins in the distal tubule | Q83948564 | ||
| The adrenogenital syndrome | Q34253530 | ||
| An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels | Q34262228 | ||
| Hypertension treatment and control in five European countries, Canada, and the United States | Q34279075 | ||
| Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes | Q34316687 | ||
| Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program | Q34373337 | ||
| Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension | Q34388923 | ||
| A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. | Q34448395 | ||
| Mammalian G proteins and their cell type specific functions | Q34453802 | ||
| Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension | Q35015795 | ||
| Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses | Q35040887 | ||
| Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. | Q35057155 | ||
| G protein-coupled receptors regulate Na+,K+-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin | Q35107902 | ||
| Two point mutations within the adducin genes are involved in blood pressure variation | Q35210045 | ||
| Haplotypes of angiotensinogen in essential hypertension | Q35250479 | ||
| Pharmacogenetics of hypertension treatment: a structured review | Q35596839 | ||
| Beta-adrenoceptor polymorphisms | Q35597242 | ||
| Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension | Q35751337 | ||
| Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans | Q35751908 | ||
| P433 | issue | 5-6 | |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | 429-469 | |
| P577 | publication date | 2007-01-30 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Genetics of arterial hypertension and hypotension | |
| P478 | volume | 374 |
| Q38623719 | A review of potential pharmacogenetic effects on catecholamine responses |
| Q35556684 | Anacardium occidentale Linn. (Anacardiaceae) stem bark extract induces hypotensive and cardio-inhibitory effects in experimental animal models |
| Q33594915 | Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension? |
| Q46214466 | Are RGS2 gene polymorphisms associated with high blood pressure in an ethnicity- and gender-specific manner? |
| Q44660587 | Association between the G protein β3 subunit C825T polymorphism and the occurrence of cardiovascular disease in hypertensives: The Nord-Trøndelag Health Study (HUNT). |
| Q50982490 | Association of G-protein β3 subunit C825T polymorphism with essential hypertension: evidence from 63 729 subjects. |
| Q30300484 | Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin receptor blockade. |
| Q34669473 | Construction and analysis of the protein-protein interaction network related to essential hypertension |
| Q33898988 | Genetics of the ceramide/sphingosine-1-phosphate rheostat in blood pressure regulation and hypertension |
| Q57174030 | Mutation in angiotensin II type 1 receptor disrupts its binding to angiotensin II leading to hypotension: An insight into hydrogen bonding patterns |
| Q35145942 | Network-based analysis of the sphingolipid metabolism in hypertension |
| Q59347457 | Pathophysiology of Hypertension |
| Q37064080 | Pharmacogenomics and migraine: possible implications |
| Q36540310 | Rgs5 targeting leads to chronic low blood pressure and a lean body habitus |
| Q86575078 | Sex differences in the blood antioxidant defense system in juvenile rats with various genetic predispositions to hypertension |
| Q30415400 | Sorting nexin 1 loss results in D5 dopamine receptor dysfunction in human renal proximal tubule cells and hypertension in mice |
| Q34779277 | β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant |
Search more.